Poland· PL-100012572
Beromun
A tasonermin product containing tasonerminum, registered in Poland by BELPHARMA s.a.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tasonermin is registered in 10 of 19 countries.
Countries holding a registration under ATC L03AX11 (tasonermin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Tasonermin · ATC L03AX11
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Tasonerminum
- Manufacturer
- BELPHARMA s.a.
- Country
- Poland (PL)
- ATC code
- L03AX11
- ATC class
- Tasonermin
- Defined daily dose
- 3.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990009008
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tasonermin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBeromun 1mg powder and solvent for solution for infusion vialsBoehringer Ingelheim Ltd
- SwedenBEROMUN 1 mg Pulver och vätska till infusionsvätska, lösningBELPHARMA s.a.
- SpainBEROMUN 1 mg POLVO PARA SOLUCION PARA PERFUSIONBelpharma S.A.
- FinlandBeromunBELPHARMA s.a.
- BelgiumBeromun 1 mgBelpharma
- IcelandBeromunBELPHARMA s.a.
- NetherlandsBeromun 1 mg poeder voor oplossing voor infusieBelpharma s.a.
- FranceBEROMUN 1 mg, poudre pour solution pour perfusionBELPHARMA (LUXEMBOURG)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Beromun
- Liechtenstein · Beromun
- Norway · Beromun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/111094a8-7cf4-4a54-9419-bd78e1fadd57 GET /v1/drugs/111094a8-7cf4-4a54-9419-bd78e1fadd57?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "1 mg",
"packaging": "05909990009008 ¦ Rpz ¦ EU/1/99/097/001 ¦ 24307\n4 fiol. 1 mg proszku",
"substance": "Tasonermin 1 mg/5 ml",
"common_name": "Tasonerminum",
"pl_product_id": "100012572",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about tasonermin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.